Anti-Müllerian hormone, better known as AMH, has become one of the most discussed tests in the context of female fertility — and one of the most frequently misunderstood. For women over 35 who are trying to conceive or simply curious about their fertility status, AMH can feel like a window into a fundamental question: how much reproductive time is left? The reality is more nuanced than that framing suggests, and understanding what AMH actually measures — and what it doesn’t — can help interpret results with appropriate context.
AMH is produced by granulosa cells in the small follicles of the ovaries and is considered a marker of ovarian reserve — the size of the remaining pool of eggs (follicles). As women age and the follicle pool diminishes, AMH levels generally decline. This makes AMH a useful clinical tool for assessing ovarian reserve compared to age-related norms. But AMH is a measure of egg quantity, not egg quality — and it’s egg quality (specifically, chromosomal integrity) that is the primary driver of fertility outcomes and miscarriage risk after 35.
What Research Shows About AMH and Fertility After 35
Research published in fertility and reproductive medicine journals consistently shows that AMH levels decline with age, with a wide range of “normal” at any given age. The relationship between AMH levels and natural conception outcomes is more complex than often presented. Studies have shown that in women who have no known infertility factors, lower AMH levels within the fertile age range do not necessarily predict a significantly reduced chance of natural conception in any given cycle — they are more strongly predictive of responses to ovarian stimulation in the context of IVF.
The National Institute of Child Health and Human Development has supported research suggesting that AMH is most clinically useful in the context of assisted reproduction planning (predicting how many eggs can be retrieved with stimulation) rather than as a standalone predictor of natural fertility. This is an important distinction that isn’t always communicated clearly in consumer-facing fertility testing contexts.
How AMH Testing Works and Is Interpreted
The Test Itself
AMH is measured through a blood test and can be taken at any point in the menstrual cycle, unlike some other fertility hormones that require specific cycle timing. This convenience has contributed to its widespread use. Results are typically reported in ng/mL or pmol/L depending on the laboratory.
What Numbers Mean in Context
Reference ranges for AMH vary by laboratory and by age. What’s considered “low” at 28 may be within the expected range at 38. This is why AMH results must be interpreted in the context of your specific age — a result that sounds numerically low in isolation may be entirely consistent with normal age-related decline rather than premature ovarian aging. Your healthcare provider is the appropriate person to interpret your specific result in context, ideally alongside other ovarian reserve markers like antral follicle count (AFC) and FSH.
The Limits of AMH Interpretation
Several factors can influence AMH levels independently of ovarian reserve, including hormonal contraceptive use (which may temporarily lower AMH in some women), certain medical conditions, and laboratory variation between different testing facilities. This means that a single AMH measurement is rarely the complete fertility picture and is best interpreted as one data point in a broader assessment. For context on how fertility testing after 35 works as a whole process, that provides helpful framing.
AMH and the Decision to Pursue Fertility Preservation
One of the contexts in which AMH testing is increasingly used is in discussions about egg freezing (oocyte cryopreservation) for women who are not yet ready to conceive. AMH results, along with other ovarian reserve markers, help fertility specialists predict how the ovaries are likely to respond to stimulation — relevant information for anyone considering this option.
However, egg freezing decisions involve many dimensions beyond AMH — including age (which influences egg quality regardless of reserve), personal circumstances, financial considerations, and realistic expectations about success rates. AMH is one input into this conversation, not the determining factor. A consultation with a reproductive endocrinologist provides a much more comprehensive framework for these decisions than AMH alone. For more context on egg quality after 35 and how it relates to fertility planning, that topic covers the quality dimension that AMH doesn’t address.
Having a Productive Conversation About AMH With Your Provider
If you’ve had an AMH test or are considering one, some questions worth exploring with your healthcare provider include:
- How does my AMH result compare to age-adjusted norms rather than general population norms?
- What does this result mean specifically for my situation — natural conception, assisted reproduction, or fertility preservation planning?
- Should this result be interpreted alongside other markers like AFC and FSH for a more complete picture?
- If my AMH is lower than expected for my age, what does that actually mean for my realistic timeline and options?
- Are there any factors that might be temporarily affecting my AMH result?
A reproductive endocrinologist or fertility specialist with experience in treating women over 35 is best positioned to contextualize these results within your full clinical picture.
The Emotional Dimension of AMH Testing
It’s worth acknowledging that AMH results can carry significant emotional weight, particularly when results are interpreted (sometimes incorrectly) as indicating limited reproductive prospects. Women who receive lower-than-expected AMH results sometimes experience significant anxiety or grief, even when those results don’t necessarily translate to the outcomes they fear. If an AMH result has caused you distress, discussing it with both your healthcare provider (for clinical context) and a mental health professional experienced in reproductive concerns (for emotional processing) can be valuable. The emotional impact of fertility testing deserves as much attention as the clinical interpretation.
Frequently Asked Questions
Can I improve my AMH levels?
AMH is primarily a reflection of the existing follicle pool, which declines with age as part of normal reproductive biology. There is no well-established intervention that reliably increases AMH levels. Some research has explored the effects of various supplements on AMH, but the evidence base is limited and results are inconsistent. Rather than focusing on trying to change the number, most reproductive specialists recommend using AMH as information to guide realistic planning conversations.
Does a low AMH mean I can’t get pregnant naturally?
Not necessarily. AMH is a marker of ovarian reserve quantity, and lower levels indicate a smaller follicle pool — but conception requires only one viable egg per cycle, and lower AMH does not mean zero eggs. Research has shown that women with low AMH who are trying to conceive naturally can and do become pregnant, though there may be less time available for cycles to occur before reserve diminishes further. Working with a reproductive specialist to understand your individual picture and appropriate timeline is more informative than AMH alone.
How often should AMH be tested?
AMH declines gradually over time, so repeat testing every one to two years may be relevant for some women who are monitoring their reproductive health trajectory. However, the appropriate frequency of testing depends on individual circumstances and goals — your healthcare provider can recommend a monitoring plan that makes sense for your situation.
Key Takeaways
- AMH is a marker of ovarian reserve (egg quantity), not egg quality — the distinction matters significantly for interpreting what results mean for fertility.
- AMH results must be interpreted in the context of age-adjusted norms; what’s considered low varies significantly with age.
- For natural conception, AMH is a less reliable predictor than commonly assumed; it is more clinically predictive of response to ovarian stimulation in IVF contexts.
- AMH is one data point in a broader fertility evaluation; antral follicle count and FSH provide complementary information.
- Reproductive endocrinologists are the most appropriate resource for interpreting AMH in the context of your individual fertility goals and clinical picture.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.